Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002YC7
CNY
10.82
-0.17 (-1.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
700.04
662.44
647.21
683.26
748.46
676.04
538.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
700.04
662.44
647.21
683.26
748.46
676.04
538.46
Raw Material Cost
286.36
291.52
244.54
225.65
227.16
191.44
201.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
132.13
99.89
84.34
76.45
67.86
65.34
58.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.16
15.33
9.24
5.41
5.05
0.57
0.80
Selling and Distribution Expenses
241.95
201.09
234.88
260.64
319.69
312.47
205.50
Other Expenses
-9.88
-7.01
-4.99
-4.27
-4.15
-3.65
-3.33
Total Expenditure (Excl Depreciation)
572.83
537.77
523.07
525.41
578.27
533.34
432.66
Operating Profit (PBDIT) excl Other Income
127.2
124.7
124.1
157.89999999999998
170.2
142.7
105.8
Other Income
83.80
17.39
16.06
12.51
14.35
6.62
6.76
Operating Profit (PBDIT)
303.96
216.66
194.61
222.01
227.60
178.21
131.25
Interest
11.16
15.33
9.24
5.41
5.05
0.57
0.80
Exceptional Items
-20.67
-6.85
-6.07
6.24
-7.11
-1.94
-0.17
Gross Profit (PBDT)
413.68
370.92
402.67
457.61
521.30
484.59
336.79
Depreciation
96.73
78.79
63.22
55.83
48.79
22.80
19.63
Profit Before Tax
175.40
115.69
116.09
167.02
166.66
152.91
110.65
Tax
17.35
12.01
2.66
26.27
23.94
21.98
15.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
200.70
162.90
161.58
170.80
165.14
131.39
96.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
200.70
162.90
161.58
170.80
165.14
131.39
96.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.09
-0.85
-0.40
0.43
-0.19
-0.43
0.48
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
200.79
162.05
161.18
171.23
164.95
130.96
97.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,260.08
1,192.31
1,087.89
986.31
873.95
756.62
660.79
Earnings per share (EPS)
0.63
0.5
0.49
0.52
0.5
0.4
0.3
Diluted Earnings per share
0.63
0.5
0.49
0.52
0.5
0.4
0.3
Operating Profit Margin (Excl OI)
17.63%
18.19%
17.82%
22.49%
21.97%
22.01%
19.47%
Gross Profit Margin
38.87%
29.36%
27.7%
32.61%
28.79%
25.99%
24.2%
PAT Margin
28.67%
24.59%
24.97%
25.0%
22.06%
19.44%
18.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 5.68% vs 2.35% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 23.95% vs 0.50% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 10.49% vs 11.59% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -26.80% vs 66.30% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
700.04
0
700.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
700.04
0
700.04
Raw Material Cost
286.36
0
286.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
132.13
0
132.13
Power Cost
0
0
0.00
Manufacturing Expenses
11.16
0
11.16
Selling and Distribution Expenses
241.95
0
241.95
Other Expenses
-9.88
0.00
-9.88
Total Expenditure (Excl Depreciation)
572.83
0
572.83
Operating Profit (PBDIT) excl Other Income
127.20
0.00
127.20
Other Income
83.80
0
83.80
Operating Profit (PBDIT)
303.96
0
303.96
Interest
11.16
0
11.16
Exceptional Items
-20.67
0
-20.67
Gross Profit (PBDT)
413.68
0
413.68
Depreciation
96.73
0
96.73
Profit Before Tax
175.40
0
175.40
Tax
17.35
0
17.35
Provisions and contingencies
0
0
0.00
Profit After Tax
200.70
0
200.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
200.70
0
200.70
Share in Profit of Associates
0
0
0.00
Minority Interest
0.09
0
0.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
200.79
0
200.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,260.08
0
1,260.08
Earnings per share (EPS)
0.63
0
0.63
Diluted Earnings per share
0.63
0
0.63
Operating Profit Margin (Excl OI)
17.63%
0%
0.00
17.63%
Gross Profit Margin
38.87%
0%
0.00
38.87%
PAT Margin
28.67%
0%
0.00
28.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 70.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 5.68% vs 2.35% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 20.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.95% vs 0.50% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.49% vs 11.59% in Dec 2023

Annual - Interest
Interest 1.12 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -26.80% vs 66.30% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.63%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023